07:24 AM EST, 11/12/2024 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) reported a Q3 loss Tuesday of $0.03 per diluted share, narrower than a loss of $0.41 a year earlier.

Four analysts polled by Capital IQ expected a loss of $0.06.

Revenue for the quarter ended Sept. 30 was $50 million compared with $7 million a year earlier.

Analysts surveyed by Capital IQ expected $48.6 million.

Price: 15.00, Change: -0.05, Percent Change: -0.33